Short-term rosiglitazone treatment in renal transplant recipients.
Ergün
Ihsan
I
Keven
Kenan
K
D016572:Cyclosporine / Q000008:administration & dosage; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000209:etiology; D004334:Drug Administration Schedule; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007333:Insulin Resistance; D016030:Kidney Transplantation / Q000009:adverse effects*; D000077154:Rosiglitazone; D016559:Tacrolimus / Q000008:administration & dosage; D045162:Thiazolidinediones / Q000008:administration & dosage*
D007004:Hypoglycemic Agents; D007166:Immunosuppressive Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D016572:Cyclosporine; D016559:Tacrolimus